Volume 14, Issue 14 p. 1321-1324
Communication

Small‐Molecule Activators of Glucose‐6‐phosphate Dehydrogenase (G6PD) Bridging the Dimer Interface

Dr. Andrew G. Raub

Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, 94305 USA

Department of Chemistry, Stanford University, Stanford, CA, 94305 USA

Search for more papers by this author
Dr. Sunhee Hwang

Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, 94305 USA

Search for more papers by this author
Dr. Naoki Horikoshi

Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba, Ibaraki, 305-8575 Japan

Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, 94305 USA

Biosciences Division, SLAC National Laboratory, Menlo Park, CA, 94025 USA

Search for more papers by this author
Dr. Anna D. Cunningham

Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, 94305 USA

Freenome Inc., 259 E. Grand Ave., South San Francisco, CA, 94080 USA

Search for more papers by this author
Dr. Simin Rahighi

Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, 94305 USA

Biosciences Division, SLAC National Laboratory, Menlo Park, CA, 94025 USA

Chapman University School of Pharmacy (CUSP), Irvine, CA, 92618 USA

Search for more papers by this author
Prof. Soichi Wakatsuki

Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, 94305 USA

Biosciences Division, SLAC National Laboratory, Menlo Park, CA, 94025 USA

Search for more papers by this author
Prof. Daria Mochly‐Rosen

Corresponding Author

Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, 94305 USA

Search for more papers by this author
First published: 11 June 2019
Citations: 3

Abstract

We recently identified AG1, a small‐molecule activator that functions by promoting oligomerization of glucose‐6‐phosphate dehydrogenase (G6PD) to the catalytically competent forms. Biochemical experiments indicate that the activation of G6PD by the original hit molecule (AG1) is noncovalent and that one C2‐symmetric region of the G6PD homodimer is important for ligand function. Consequently, the disulfide in AG1 is not required for activation of G6PD, and a number of analogues were prepared without this reactive moiety. Our study supports a mechanism of action whereby AG1 bridges the dimer interface at the structural nicotinamide adenine dinucleotide phosphate (NADP+) binding sites of two interacting G6PD monomers. Small molecules that promote G6PD oligomerization have the potential to provide a first‐in‐class treatment for G6PD deficiency. This general strategy could be applied to other enzyme deficiencies in which control of oligomerization can enhance enzymatic activity and/or stability.